Simplex Trading
MAZE

Simplex Trading’s Maze Therapeutics MAZE Stock Holding History

Simplex Trading’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Sell
1,200
-200
-14% -$5.24K ﹤0.01% 6609
2026
Q1 		$41.8K Buy
+1,400
New +$61.8K ﹤0.01% 6063

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Simplex Trading's MAZE Position: Q2 2026 in Review

Simplex Trading reduced its Maze Therapeutics (MAZE) stake by 3.6% in Q2 2026, selling an estimated $1.15K and leaving 1,166 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6636.

Simplex Trading first reported a position in MAZE in Q1 2026 and has held it in 2 quarters since. The position peaked at $36.1K in Q1 2026. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Simplex Trading held 1,166 shares of Maze Therapeutics worth $34.8K as of Q2 2026.
  • Simplex Trading sold 44 Maze Therapeutics shares in Q2 2026, an estimated $1.15K.
  • Maze Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6636 holding.
  • Simplex Trading first reported a position in Maze Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Simplex Trading's Maze Therapeutics position peaked at $36.1K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.